98%
921
2 minutes
20
Black women living with HIV (BWLWH) contend with injuries of injustice, which manifest in restricted reproductive autonomy and decision-making power in social and medical settings. Mitigating threats to reproductive autonomy calls for innovations that consider patients' needs and offer insights on how historically situated marginalization influences today's institutional, political, and economic systems and shapes reproductive decision making. In addition to cross-disciplinary expertise and collaboration, integrating structural competency into reproductive health care requires demonstrating respect for the autonomy, lived experiences, and preferences of BWLWH.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/amajethics.2021.156 | DOI Listing |
JAMA Intern Med
September 2025
Bayer CC AG, Basel, Switzerland.
Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.
Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.
Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).
Int J Womens Dermatol
October 2025
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Background: Few studies have comprehensively assessed dermatologic conditions in women, particularly among different racial and ethnic groups.
Objective: This study characterizes common dermatologic diagnoses in adult women (acne), emphasizing conditions disproportionately affecting women of color (WOC) (hidradenitis suppurativa [HS], hypertrophic scars, and scarring and nonscarring alopecia).
Methods: This retrospective cohort study analyzed data from Northwestern Medicine's Enterprise Data Warehouse, covering 637,124 patient visits from 2018 to 2021.
Urol Case Rep
September 2025
Main Line Health, Division of Urology, Wynnewood, PA, USA.
Muscle-invasive bladder cancer (MIBC) with cardiac metastasis typically carries a very poor prognosis. A Black woman in her 70s developed high-grade urothelial carcinoma with squamous differentiation invading the bladder muscle. Despite chemotherapy, radiation, and nephrostomy, the disease progressed.
View Article and Find Full Text PDFAm J Prev Cardiol
September 2025
Department of Cardiology, Albert Einstein College of Medicine/ Montefiore Medical Center, Bronx, NY, USA.
Background: Hispanics/Latinos are a heterogenous population with no validated atherosclerotic cardiovascular disease (ASCVD) risk estimation tool. We examined performance of the pooled cohort equation (PCE) across Hispanic/Latino background groups and quantiles of African, Amerindian, and European genetic ancestry.
Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) was used to evaluate the performance of the non-Hispanic Black (NHB) and non-Hispanic White (NHW) PCE defined by predicted to observed (P/O) ratios of 10-year ASCVD events.
Health Equity
August 2025
The Afiya Center, Reproductive Justice Organization, Dallas, Texas, USA.
Amber Thurman, Candi Miller, Porsha Ngumezi, Josseli Barnica, and Neveah Crain highlight the tragic outcomes of restrictive abortion bans post-Dobbs v. Jackson Women's Health Organization. Their stories underscore the need to shift away from viewing medical institutions as the only sources of reproductive care.
View Article and Find Full Text PDF